Arthritis drug and remdesivir shortens hospital stays for COVID-19

Arthritis drug may boost remdesivir’s benefits for COVID-19 sufferers: Patients given both drugs spent one day less in the hospital compared to those who only got Gilead’s antiviral Eli Lilly announced  Monday that its anti-inflammatory drug baricitinib used in combination with remdesivir showed promising benefit COVID-19 patients who got both drugs in the 1,000-person NIH study were well enough to leave the […]

» Read more

Some doctors still prescribing antibiotics with terrible side-effects

Tinnitus, nerve damage and a racing pulse from just TWO antibiotic pills… Despite warnings, some doctors are still prescribing drugs that can leave patients with crippling side-effects After being prescribed antibiotics for a suspected urinary tract infection (UTI), Adam Sawczuk was expecting to bounce back to health within days. He’d had stabbing pain and a dull ache in his groin […]

» Read more

A woman with stage 4 cancer had to road-trip across the US at the height of lockdown. Here’s how she did it without getting sick.

When most people with compromised immune systems were sheltering in place, Emily Veach, a 38-year-old woman with advanced cancer, embarked on a 2,400-mile cross-country road trip to move closer to family.  In some ways, her experience with a life-threatening illness and confronting mortality made her better prepared for the pandemic than many healthy people.  To keep herself safe while traveling, […]

» Read more

Children spread coronavirus to family members following exposure at child care facilities, CDC says

Fox News Flash top headlines for September 14 Children transmit coronavirus to their family members following exposure at child care facilities, according to a Centers for Disease Control and Prevention (CDC) report released Friday. The study looked at data collected from contact tracing during outbreaks of COVID-19 infections in three Salt Lake City, Utah, child care facilities between April and July. “Twelve children acquired COVID-19 […]

» Read more

No benefit from drug used to reduce heart disease in kidney patients

Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease. The drug is routinely prescribed to patients with chronic kidney disease to help reduce the risk of both bone disease and cardiovascular disease, with cardiovascular disease the most common complication and cause of death […]

» Read more
1 1,158 1,159 1,160 1,161 1,162 1,330